Puma Biotechnology, Inc. PBYI

Healthcare · Biotechnology · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$651.46M
Market Cap
$569.42M
Margin of Safety
12.6%
Intrinsic / Market Ratio
1.14

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

255.17M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

1.56B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

138.68M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

651.46M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

651.46M USD

from the sum above

Market Cap

569.42M USD

today's price times the shares

Intrinsic Value ÷ Market Cap

1.14×

the ratio the screener ranks by; Margin of Safety +12.6% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 255.17M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)165.99M USD
+②Net Cash Today89.18M USD
+③Growth Value0 USD
=Value255.17M USD

EPV of the Operations (NOPAT over WACC)

165.99M USD

Net cash today

+89.18M USD

Growth Value

0 USD

Value

255.17M USD

①EPV (earnings power value)

165.99M USD

②Net Cash Today

89.18M USD

③Growth Value

0 USD

Market value

Market Cap569.42M USD

Today's price times the shares.

Value vs market

Margin of Safety-123.2%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 1.56B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE1.11B USD
+②Equity at Year 15, Today453.49M USD
=Value1.56B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

1.11B USD

②Equity at Year 15, Today

453.49M USD

Market value

Market Cap569.42M USD

Today's price times the shares.

Value vs market

Margin of Safety+63.5%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 138.68M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 138.68M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap569.42M USD

Today's price times the shares.

Value vs market

Margin of Safety-310.6%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 12.66%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 1.21×Market Risk Premium 6.00%= 11.75%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 4.68M USDPretax Income 35.82M USD= 13.05%

The tax the interest saves.

Interest Expense =EBIT 42.45M USD−Pretax Income 35.82M USD= 6.63M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 6.63M USDTotal Debt 4.82M USD×(1 − Tax Rate for WACC 13.05%)= 119.53%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 4.82M USDMarket Cap + Total Debt 569.42M USD + 4.82M USD= 0.84%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.16%×Cost of Equity 11.75%+Debt Weight 0.84%×Cost of Debt 119.53%= 12.66%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 192.93M USD − Total Liabilities 54.25M USD = Book Value Today 138.68M USD

Total Debt 4.82M USD − Cash and Short-Term Investments 94.00M USD = Net Debt Today -89.18M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 17.3%at most 5%does not pass51,102,687 / 47,646,787
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets5.5%at least -10.0%passes(41.84M USD − 31.14M USD) ÷ 192.93M USD
Price to bookMarket Cap ÷ Book Value Today4.11×at most 3×does not pass569.42M USD ÷ 138.68M USD
Operating marginOperating Income ÷ Revenue16.3%above 10.0%passes37.34M USD ÷ 228.60M USD
Revenue growthRevenue ÷ Revenue a Year Before − 1-0.9%above 10.0%does not pass228.60M USD / 230.70M USD
Net cash(Cash − Total Debt) ÷ Market Cap5.6%above -30%passes(36.57M USD − 4.82M USD) ÷ 569.42M USD
Operating efficiencyOperating Income ÷ Gross Profit21.9%above 25.0%does not pass37.34M USD ÷ 170.38M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

11 USD

Enterprise value

480.25M USD

market cap plus net debt

EV / EBITDA

11.96×

Price / book

4.06×

the provider's book

Price / earnings

21.61×

Return on equity

22.0%

the provider's, not the engine's

Profit margin

11.6%

Revenue growth

7.8%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

228.26M235.87M230.70M228.60M

Gross profit

173.11M173.13M166.23M170.38M

Operating income

30.75M32.67M31.00M37.34M

EBITDA

operating income before depreciation and amortisation

21.91M47.57M48.12M53.40M

Pretax income

457.46K22.70M24.12M35.82M

Net income

2.00K21.61M30.31M31.14M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

15.39M21.61M30.31M31.14M

R&D

52.29M50.43M54.99M62.13M
Balance sheet, year end

Total assets

222.28M230.76M213.55M216.52M

Total liabilities

200.65M177.26M121.33M86.05M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

21.63M53.50M92.22M130.47M

Total debt

114.40M111.60M74.16M28.57M

Cash and equivalents

76.28M84.67M69.29M29.66M

Net PP&E

fixed assets after depreciation

12.52M8.66M5.10M5.57M

Working capital

current assets less current liabilities

56.85M56.86M51.60M81.51M
Cash flow

Operating cash flow

-15.84M27.04M38.96M41.84M

Capital expenditure

paid out, so below zero

-7.01M-12.65M-56.06K-71.07K

Depreciation and amortisation

9.85M11.53M11.54M10.95M

Free cash flow

operating cash flow plus capital expenditure

-22.85M14.38M38.90M41.77M